Skip to main content
GENEDRIVE PLC logo

GENEDRIVE PLC — Investor Relations & Filings

Ticker · GDR ISIN · GB00B1VKB244 LEI · 213800ZYODIRZ87Y4K14 IL Manufacturing
Open in API
Filings indexed 606 across all filing types
Latest filing 2024-12-20 Director's Dealing
Country GB United Kingdom
Listing IL GDR

About GENEDRIVE PLC

https://genedriveplc.com/

Genedrive PLC is a molecular diagnostics company specializing in the development and commercialization of a rapid, point-of-care pharmacogenetic testing platform. The company's core technology, the Genedrive® System, is designed for the swift diagnosis of genetic variants to enable personalized medicine in critical care settings. Its key products include the Genedrive® MT-RNR1 ID Kit, used to prevent antibiotic-induced hearing loss in infants, and the Genedrive® CYP2C19 ID Kit, which helps optimize antiplatelet therapy for stroke patients. The platform empowers clinicians to make safer and more effective treatment decisions by providing crucial genetic information at the point of need, thereby improving patient outcomes.

Recent filings

Filing Released Lang Actions
Director/PDMR Shareholding
Director's Dealing Classification · 1% confidence The document is titled 'Director/PDMR Notification' and details the purchase of ordinary shares by several directors and persons discharging managerial responsibilities (PDMRs) of genedrive plc. It explicitly states the nature of the transaction ('Purchase of ordinary shares') and provides aggregated information on price and volume, which is characteristic of insider trading or director's dealing disclosures required by market regulators. The presence of 'RNS Number' and the closing statement referencing RNS, the news service of the London Stock Exchange, confirms it is a regulatory announcement. This directly maps to the 'Director's Dealing' category (DIRS).
2024-12-20 English
Posting of annual report and notice of AGM
Report Publication Announcement Classification · 1% confidence The document is a regulatory announcement (RNS Number: 0223P) dated December 5, 2024. The title explicitly states: "Posting of Annual Report and Accounts and notice of AGM". The text confirms that the 2024 Annual Report and Accounts are now available and that the Notice of the 2024 Annual General Meeting ("AGM") will be posted. Since the document's primary function is to announce the publication of the Annual Report and the AGM notice, and given its short length (under 5,000 characters), it fits the definition of a Report Publication Announcement (RPA) rather than the full Annual Report (10-K) or the AGM materials (AGM-R) themselves. It is announcing the availability of those reports.
2024-12-05 English
Block listing returns
Share Issue/Capital Change Classification · 1% confidence The document starts with 'RNS Number : 2284O' and explicitly mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'Block Listing Returns' for share option schemes over a specific period (01 June 2024 to 29 November 2024), which is a regulatory filing requirement, often related to capital structure or share issuance disclosures. Since this is a specific regulatory announcement distributed via the RNS system and does not fit neatly into categories like 10-K, ER, or DIV, the most appropriate classification is the general regulatory announcement category, RNS.
2024-11-29 English
Final Results
Annual Report Classification · 1% confidence The document is titled 'Audited Final Results' for Genedrive PLC for the year ended 30 June 2024. It contains financial highlights, operational highlights, a Chairman's Statement, and a Chief Executive's Review. While it is an announcement of results, it provides substantive financial data and analysis, and is clearly the primary annual financial disclosure document for the company. Therefore, it is classified as an Annual Report (10-K equivalent for a UK-listed company). FY 2024
2024-11-29 English
Notice of Results
Report Publication Announcement Classification · 1% confidence The document is an RNS announcement (RNS Number: 1992N) from Genedrive PLC. The title is "Notice of Results Investor Presentation". The content explicitly states that the company "announces it will release its preliminary results for the year ended 30 June 2024 on Friday, 29 November 2024" and that it "will provide a live presentation to accompany the results". This document is not the results themselves (ER or IR), nor is it the presentation (IP). It is an announcement about the future publication of results and a related presentation event. According to Rule 2, when a document announces the publication of another report or event, it often falls under Report Publication Announcement (RPA) or a general Regulatory Filing (RNS). Since this specifically announces the timing of a results release and an accompanying presentation, RPA is the most precise fit, as it signals the upcoming release of other documents.
2024-11-22 English
NIHR and OLS Funding Package
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 1836N' and is dated November 21, 2024. It announces a successful funding award for the Genedrive® MT-RNR1 ID Kit from NIHR and OLS, detailing the expected revenue (£500k) and the purpose (addressing NICE evidence requirements). The text concludes with contact information and a footer explicitly stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This structure—a brief announcement of a material event distributed via the RNS system—is characteristic of a general regulatory announcement that doesn't fit a more specific category like Earnings Release (ER) or Capital Update (CAP). Since it is a general regulatory announcement distributed through the official channel, the most appropriate classification is Regulatory Filings (RNS). The document length (7123 chars) is substantial enough that it is not merely an announcement *about* a report, but the report itself, which is a regulatory filing.
2024-11-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.